SORRENTO THERAPEUTICS

YTD

ALL

Why Robinhood?

You can watch SRNE and buy or sell other stocks, ETFs, and their options commission-free!

About SRNE

Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments.

CEO

Henry H. Ji, PhD

CEOHenry H. Ji, PhD

Employees

—

Employees—

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1989

Founded1989

Employees

—

Employees—

SRNE Key Statistics

Market cap

496.20K

Market cap496.20K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

102.54K

Average volume102.54K

High today

$0.0009

High today$0.0009

Low today

$0.0009

Low today$0.0009

Open price

$0.0009

Open price$0.0009

Volume

91.78K

Volume91.78K

52 Week high

$0.026

52 Week high$0.026

52 Week low

$0.0001

52 Week low$0.0001

People also own

Based on the portfolios of people who own SRNE. This list is generated using Robinhood data, and it’s not a recommendation.

SORRENTO THERAPEUTICS

Why Robinhood?

Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments. Show more

SRNE Key Statistics

People also own

Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments.